Temsirolimus Kit
Product Images NDC 16729-223

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Temsirolimus (NDC 16729-223). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (25 mg)

The text is a combination of medical vocabulary and random phrases. It contains information about Temsirolimus injectons, such as the dosage, concentration, dilution, and refrigeration requirements. The text also mentions a single dose vial and diluent for the injectons. However, it is not clear what the context or purpose of the text is.*

FDA Label Image

Figure 1 (Temsirolimus Injection Figure)

The text seems to be describing a graph or chart that shows the Kaplan-Meier curves for overall survival with Temsirolimus vs. IFN, with months to death from randomization on the x-axis and survival distribution function on the y-axis. However, without the actual visual, it is impossible to provide a more detailed description.*

FDA Label Image

Principal Display Panel (1.8 mL)

This is a medication description for NDC 16729-222-30 which is a diluent for Temsirolimus injection vial. It is a refrigerated single dose and is not for direct administration but only for dilution purposes. The usage instructions can be found in the insert. The medication is manufactured for Accord Healthcare, Inc. and manufactured by Intas Pharmaceuticals Limited in Ahmedabad, India. The description also includes a lot and batch number for reference.*

FDA Label Image

Principal Display Panel (25 mg/mL)

This appears to be instructions for diluting a substance to a concentration of 10 mg/mL using a two-step dilution process. The dilution involves adding 1.8 mL of diluent to achieve the desired concentration. However, without more context or information about the substance being diluted, it is difficult to provide a more specific description.*

FDA Label Image

Structure (Temsirolimus Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.